FY2025 EPS Estimates for ADMA Biologics Lowered by Analyst
ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of ADMA Biologics in a note issued to investors on Thursday, May 8th. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will post earnings of $0.72 per share for the year, down […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of ADMA Biologics in a note issued to investors on Thursday, May 8th. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will post earnings of $0.72 per share for the year, down […]
